This document provides a six-step process for interpreting arterial blood gas (ABG) results. It begins by emphasizing the importance of ABG interpretation for healthcare providers. The six steps include: 1) assessing internal consistency, 2) identifying alkalemia or acidemia, 3) determining if the disturbance is respiratory or metabolic, 4) checking for appropriate compensation, 5) calculating anion gap if needed, and 6) assessing the relationship between anion gap and bicarbonate changes. Common acid-base disorders and their characteristics are also outlined. The goal of the interpretation is to identify primary and concurrent acid-base abnormalities.
ABGs or VBGs interpretation made simple straight forward easy to remember and easy to apply. The presentation is designed to help the residents and junior ER physicians. The second part will discuss the oxygenation and the third part will review the "Stewart Approach" while fourth and last part is meant for the Experts.
ABGs or VBGs interpretation made simple straight forward easy to remember and easy to apply. The presentation is designed to help the residents and junior ER physicians. The second part will discuss the oxygenation and the third part will review the "Stewart Approach" while fourth and last part is meant for the Experts.
one can learn the step by step approach of ABG interpritation and its analysis from basics with the help of different case scenarios,Ref-NEJM article regarding physiological approach to acid base disbalance
one can learn the step by step approach of ABG interpritation and its analysis from basics with the help of different case scenarios,Ref-NEJM article regarding physiological approach to acid base disbalance
New technology called Electromagnetic Navigation Bronchoscopy® (ENB) that uses virtual bronchoscopy and real time 3-dimensional CT images that enable me to localize these peripheral lung nodules for diagnosis and treatment. This outpatient procedure is minimally invasive and therefore has a small risk of pneumothorax (2-3%) and its published diagnostic yield rates range from 67% - 86%
Presentation by Dr. Mishal Saleem on Topic: Step wise approach to abgs interpretation.
Use of delta ratio and delta gap
Use of Anion Gap
Use of Urinary anion gap
Oxygen Therapy is not Beneficial in COPD Patients with Moderate HypoxaemiaGamal Agmy
A Randomized Trial of Long-Term Oxygen for COPD with Moderate Desaturation
The Long-Term Oxygen Treatment Trial Research Group*
N Engl J Med. 2016 October 27; 375(17): 1617–1627
Muktapishti is a traditional Ayurvedic preparation made from Shoditha Mukta (Purified Pearl), is believed to help regulate thyroid function and reduce symptoms of hyperthyroidism due to its cooling and balancing properties. Clinical evidence on its efficacy remains limited, necessitating further research to validate its therapeutic benefits.
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
2. • Interpreting an arterial blood gas (ABG)
is a crucial skill for physicians, nurses,
respiratory therapists, and other health
care personnel. ABG interpretation is
especially important in critically ill
patients.
3. • The following six-step process helps
ensure a complete interpretation of
every ABG. In addition, you will find
tables that list commonly encountered
acid-base disorders.
4. •Step 1
• Assess the internal consistency of the
values using the Henderseon-
Hasselbach equation:
[H+] = 24(PaCO2)
[HCO3-]
• If the pH and the [H+] are inconsistent,
the ABG is probably not valid.
6. •Step 2
• Is there alkalemia or acidemia
present?
• pH < 7.35 acidemia
• pH > 7.45 alkalemia
• This is usually the primary disorder
• Remember: an acidosis or alkalosis
may be present even if the pH is in
the normal range (7.35 – 7.45)
• You will need to check the PaCO2,
HCO3- and anion gap
7. •Step 3
• Is the disturbance respiratory or
metabolic?
• What is the relationship between the
direction of change in the pH and the
direction of change in the PaCO2?
• In primary respiratory disorders, the pH
and PaCO2 change
in opposite directions; in metabolic
disorders the pH and PaCO2 change in
the same direction.
9. •Step 4
• Is there appropriate compensation for
the primary disturbance? Usually,
compensation does not return the pH to
normal (7.35 – 7.45).
10. Disorder Expected compensation
Metabolic acidosis PaCO2 = (1.5 x [HCO3-]) +8
Acute respiratory
acidosis
Increase in [HCO3-]= ∆ PaCO2/10
Chronic respiratory
acidosis (3-5 days)
Increase in [HCO3-]= 3.5(∆ PaCO2/10)
Metabolic alkalosis Increase in PaCO2 = 40 + 0.6(∆HCO3-)
Acute respiratory
alkalosis
Decrease in [HCO3-]= 2(∆ PaCO2/10)
Chronic respiratory
alkalosis
Decrease in [HCO3-] = 5(∆ PaCO2/10)
to 7(∆ PaCO2/10)
11. • If the observed compensation is not the
expected compensation, it is likely that
more than one acid-base disorder is
present.
12. •Step 5
• Calculate the anion gap (if a metabolic
acidosis exists): AG= [Na+]-( [Cl-] +
[HCO3-] )-12 ± 2
• A normal anion gap is approximately
12 meq/L.
13. •Step 5
• In patients with hypoalbuminemia, the normal
anion gap is lower than 12 meq/L; the “normal”
anion gap in patients with hypoalbuminemia is
about 2.5 meq/L lower for each 1 gm/dL
decrease in the plasma albumin concentration
(for example, a patient with a plasma albumin of
2.0 gm/dL would be approximately 7 meq/L.)
14. •Step 5
• If the anion gap is elevated, consider
calculating the osmolal gap in compatible
clinical situations.
– Elevation in AG is not explained by an obvious case
(DKA, lactic acidosis, renal failure
– Toxic ingestion is suspected
• OSM gap = measured OSM – (2[Na+] -
glucose/18 – BUN/2.8
– The OSM gap should be < 10
15. •Step 6
If an increased anion gap is present,
assess the relationship between the
increase in the anion gap and the
decrease in [HCO3-].
16. •Step 6
• Assess the ratio of the change in the anion
gap (∆AG ) to the change in [HCO3-]
(∆[HCO3-]): ∆AG/∆[HCO3-]
• This ratio should be between 1.0 and 2.0 if
an uncomplicated anion gap metabolic
acidosis is present.
• If this ratio falls outside of this range, then
another metabolic disorder is present:
• If ∆AG/∆[HCO3-] < 1.0, then a concurrent
non-anion gap metabolic acidosis is likely to
be present.
17. •Step 6
• If ∆AG/∆[HCO3-] < 1.0, then a concurrent
non-anion gap metabolic acidosis is likely to
be present.
• If ∆AG/∆[HCO3-] > 2.0, then a concurrent
metabolic alkalosis is likely to be present.
• It is important to remember what the
expected “normal” anion gap for your patient
should be, by adjusting for hypoalbuminemia
21. Selected causes of metabolic alkalosis
• Hypovolemia with Cl- depletion
– GI loss of H+
• Vomiting, gastric suction, villous adenoma, diarrhea with
chloride-rich fluid
– Renal loss H+
• Loop and thiazide diuretics, post-hypercapnia (especially
after institution of mechanical ventilation)
• Hypervolemia, Cl- expansion
– Renal loss of H+: edematous states (heart failure,
cirrhosis, nephrotic syndrome), hyperaldosteronism,
hypercortisolism, excess ACTH, exogenous
steroids, hyperreninemia, severe hypokalemia,
renal artery stenosis, bicarbonate administration
22. Selected etiologies of metabolic acidosis
Elevated anion gap:
Methanol intoxication
Uremia
Diabetic ketoacidosisa, alcoholic ketoacidosis, starvation
ketoacidosis
Paraldehyde toxicity
Isoniazid
Lactic acidosisa
Type A: tissue ischemia
Type B: Altered cellular metabolism
Ethanol or ethylene glycol intoxication
Salicylate intoxication
a Most common causes of metabolic acidosis with an elevated
anion gap Frequently associated with an osmolal gap
23. Selected etiologies of metabolic acidosis
Normal anion gap: will have increase in [Cl-]
GI loss of HCO3-
Diarrhea, ileostomy, proximal colostomy, ureteral
diversion
Renal loss of HCO3-
proximal RTA
carbonic anhydrase inhibitor (acetazolamide)
Renal tubular disease
ATN
Chronic renal disease
Distal RTA
Aldosterone inhibitors or absence
NaCl infusion, TPN, NH4+ administration
24. Disorder Characteristics Selected situations
Respiratory
acidosis with
metabolic
acidosis
↓in pH
↓ in HCO3
↑ in PaCO2
Cardiac arrest
Intoxications
Multi-organ failure
Respiratory alkalosis
with metabolic
alkalosis
↑in pH
↑ in HCO3-
↓ in PaCO2
Cirrhosis with diuretics
Pregnancy with vomiting
Over ventilation of COPD
Respiratory acidosis
with metabolic
alkalosis
pH in normal range
↑ in PaCO2,
↑ in HCO3-
COPD with diuretics, vomiting,
NG suction
Severe hypokalemia
25. Respiratory
alkalosis with
metabolic
acidosis
pH in normal
Range
↓ in PaCO2
↓ in
HCO3
Sepsis
Salicylate
toxicity
Renal failure
with CHF or
pneumonia
Advanced liver
disease
Metabolic acidosis
with metabolic
alkalosis
pH in normal
range
HCO3-
normal
Uremia or
ketoacidosis
with vomiting,
NG suction,
diuretics, etc.